At the news
? BEARISHIMPACT 6/10 PRESS-RELEASE filed Nov 5, 2026 at 16:15 ET
AMN Healthcare reported Q3 2026 revenue of $717M (13% YoY growth) and adjusted EPS of $1.16, significantly exceeding the consensus estimate of $0.23. However, Q4 guidance projects a sharp decline to $655-$670M revenue (down 10-12% YoY) and adjusted EBITDA margin of only 5.8%-6.3%, reflecting the expected collapse in labor disruption revenue from $124M in Q4 2025 to just $5M.
- Q3 2026 revenue $717.3M, +13% YoY, above $649.5M consensus
- Adjusted diluted EPS $1.16 vs consensus $0.23 (strong beat)
- Q4 2026 revenue guidance $655-$670M, down 10-12% YoY
- Q4 adjusted EBITDA margin guided to 5.8%-6.3%, down from 13.0% in Q3
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access